| Literature DB >> 28332493 |
Mark D White1, Maria Klecker2,3, Richard J Hopkinson1, Daan A Weits4, Carolin Mueller5,6, Christin Naumann2,3, Rebecca O'Neill1, James Wickens1, Jiayu Yang1, Jonathan C Brooks-Bartlett7, Elspeth F Garman7, Tom N Grossmann5,6, Nico Dissmeyer2,3, Emily Flashman1.
Abstract
Crop yield loss due to flooding is a threat to food security. Submergence-induced hypoxia in plants results in stabilization of group VII ETHYLENE RESPONSE FACTORs (ERF-VIIs), which aid survival under these adverse conditions. ERF-VII stability is controlled by the N-end rule pathway, which proposes that ERF-VII N-terminal cysteine oxidation in normoxia enables arginylation followed by proteasomal degradation. The PLANT CYSTEINE OXIDASEs (PCOs) have been identified as catalysts of this oxidation. ERF-VII stabilization in hypoxia presumably arises from reduced PCO activity. We directly demonstrate that PCO dioxygenase activity produces Cys-sulfinic acid at the N terminus of an ERF-VII peptide, which then undergoes efficient arginylation by an arginyl transferase (ATE1). This provides molecular evidence of N-terminal Cys-sulfinic acid formation and arginylation by N-end rule pathway components, and a substrate of ATE1 in plants. The PCOs and ATE1 may be viable intervention targets to stabilize N-end rule substrates, including ERF-VIIs, to enhance submergence tolerance in agriculture.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28332493 PMCID: PMC5376641 DOI: 10.1038/ncomms14690
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Figure 1O2-dependent Cys-modification of a RAP22–11 peptide substrate.
MALDI–MS spectra showing the RAP2-11 peptide species identified following incubation with PCO1 and PCO4 under anaerobic (a) or aerobic (b) conditions. Products with mass increases of +32 Da and +48 Da were only observed in the presence of PCO1 or PCO4 and O2.
Figure 2PCOs catalyse incorporation of molecular O2 into RAP22–11.
(a) MALDI–MS spectra showing that PCO4-catalysed reactions carried out in the presence of 18O2 result in a +4 Da increase in the mass of the putative Cys-sulfinic acid product; however, a +6 Da increase in the size of the putative Cys-sulfonic acid product is not observed; (b) MALDI–MS spectra showing that PCO4-catalysed reactions carried out in the presence of H218O show no additional incorporation of mass compared with products of reactions in the presence of H216O; (c) LC–MS spectra confirm that the +48 Da reaction product is an artefact of MALDI–MS analysis (Supplementary Fig. 3) and incubation of PCO1 and PCO4 with RAP22–11 results in formation of a single product with a mass increase of +32 Da, consistent with Cys-sulfinic acid formation.
Figure 3PCO1 and PCO4 oxidize the N-terminal Cys of RAP22–11 to Cys-sulfinic acid.
(a) Peptidic products of PCO-catalysed reactions were subjected to LC–MS/MS analysis. In the presence of enzyme, fragment assignment was consistent with expected b- and y-series ion masses for RAP22–11 with N-terminal Cys-sulfinic acid. (b) 1H-NMR was used to monitor changes to RAP22–11 (500 μM) upon incubation with enzyme (5 μM). In the presence of PCO1 (red) and PCO4 (purple), the 1H-resonance at δH 2.88 p.p.m. (assigned to the β-cysteinyl protons of RAP22–11, blue) was observed to decrease in intensity, with concomitant emergence of a resonance at δH 2.67 p.p.m. This new resonance was assigned to the β-protons of Cys-sulfinic based on chemical shift analysis (see Supplementary Fig. 4).
Figure 4PCO-catalysed Cys-sulfinic acid formation renders RAP22–13 a substrate for ATE1-catalysed arginylation.
(a) 14C-Arg incorporation by ATE1 into the 12-mer N-terminal ERF-VII peptide (H2N-XGGAIISDFIPP(PEG)K(biotin)-NH2, X=Gly, Asp, Cys or Cys-sulfonic acid (C(O3))), was assayed by liquid scintillation counting of immobilized biotinylated peptides after the arginylation reaction and removal of unreacted 14C-Arg (n=3). In the case of the Cys-starting peptide (RAP22–13), ATE1 activity was strongly dependent on the presence of PCO1 or PCO4. n=3, error bars in this panel represent s.e.m. (b) Scheme showing PCO- and ATE1-catalysed reactions on Nt-Cys of ERF-VIIs, as validated in this study. (c) LC–MS spectra of products of equivalent assays with Cys-initiated RAP22–13 using non-radiolabelled Arg, revealing a sequential mass increase of +32 (corresponding to oxidation) and +156 Da (corresponding to arginylation) only in the presence of PCO and ATE1 (blue spectrum). The red spectrum shows a +32 Da mass increase for Cys-RAP22–13 incubated +PCO/−ATE, demonstrating Cys-sulfinic acid formation as expected. Purple spectra show +12 Da species formed upon incubation of Cys-RAP22–13 in the absence of PCO+/−ATE (for explanation of this mass increase see text and Supplementary Fig. 6); the black spectrum shows Cys-RAP22–13 dissolved in H2O. (d) b- and y-ion series spectra generated by MS/MS analysis of Cys-RAP22–13 only (no incubation; black), Cys-RAP22–13 incubated +PCO/−ATE (red), Cys-RAP22–13 incubated +PCO/+ ATE1 (blue) and Cys-RAP22–13 incubated −PCO/− ATE1 (purple), confirming arginylation only at the N terminus of PCO-modified RAP22–13.